MAPT and early-onset autosomal dominant Alzheimer disease: Tau is involved in the Aβ-induced downregulation of BDNF; hence, Alzheimer’s disease treatments that focus solely on Aβ may be ineffective if the impact of Tau pathology on neurotrophic pathways is not considered [41].